Lizong Shen

8PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMolecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 24, 2026
Serglycin Drives LAG3+ Treg Differentiation and Immunosuppression in Gastric Cancer.

Qingyuan Wang, Peng Xu, Jia Chen

|Dec 21, 2025
CD146+ CAFs mediate immunosuppression in gastric cancer via COL4A1: potential therapeutic targets.

Jia Chen, Peng Xu, Qingyuan Wang

|Jun 11, 2024
Tumour cell-derived serglycin promotes IL-8 secretion of CAFs in gastric cancer.

Xiang Li, Guiping Xie, Jia Chen

|May 28, 2022
Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8+ T cells.

Xiang Li, Jing Zhai, Yuke Shen

|Nov 01, 2021
Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer.

Tiancheng Zhang, Xiang Li, Yani He

|Apr 01, 2021
Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy.

Xia Liu, Celine L Hartman, Lingyun Li

Pageof 2